Market Tracker

04/24 5:15pm ET

Biomarin Pharmaceutical Inc (NASDAQ:BMRN)

81.13
Delayed Data
As of Apr 24
 -0.95 / -1.16%
Today’s Change
75.81
Today|||52-Week Range
100.51
-9.02%
Year-to-Date

Today’s Trading

Previous close82.08
Today’s open82.91
Day’s range80.90 - 83.49
Volume907,132
Average volume (3 months)1,316,655
Market cap$14.8B
Data as of 4:15pm ET, 04/24/2018

Growth & Valuation

Earnings growth (last year)+82.41%
Earnings growth (this year)+4.65%
Earnings growth (next 5 years)+77.10%
Revenue growth (last year)+18.75%
P/E ratioNM
Price/Sales11.79
Price/Book5.25

Competitors

 Today’s
change
Today’s
% change
MYLMylan NV-0.53-1.30%
PRGOPerrigo Company PLC-1.42-1.73%
JAZZJazz Pharmaceuticals...-1.13-0.73%
ALNYAlnylam Pharmaceutic...-1.13-1.18%
Data as of 4:02pm ET, 04/24/2018

Financials

Last reporting dateApril 25, 2018
EPS forecast (this quarter)-$0.16
Annual revenue (last year)$1.3B
Annual profit (last year)-$117.0M
Net profit margin-8.87%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Jean-Jacques Bienaimé
Chief Financial Officer &
Executive Vice President
Dan Spiegelman
Corporate headquarters
San Rafael, California

Forecasts